Get started
11/5/24 - $hwm - One to buy on dips, solid biz11/5/24 :: VROCKSTAR :: NYSE:HWM One to buy on dips, solid biz - tryin' to get ahead of rest of EPS pile today/tmr - this one reports Wed AM (after we learn which fruit pie won at the county fair) - i digress - this thing is such a solid biz. genuinely feel life i've missed "the move", b/c at 2.2-2.5% fcf yield growing HSD-low doubles, and 33x next year PE, there's not too much on the valuation side that's giving me that great R/R - on the converse, dips will likely be bought hardcore and "space" is a theme not going away and these guys have solid margins, a nice niche (lightweight metal mfg for key parts/ components), no stock based shenanigans like tech bro co's... it's a great biz - a warren buffett stock, let's say - so while i'd probably be tempted to buy a dip if say today we dive into the close on a risk-off situation (and it's flows related)... i might just have to sit this one out and wait for more of a macro pullback where the tide dunks all boats for the time being. - that gap in the 70s would be "obvious" buy. but honestly, if we get there something's probably wrong. i think low 90s is good value and in the 80s is a solid place to get busy with a 1% stake. so setting my alarms accordingly and will monitor for the day, otherwise will report back if/when. - congrats to the longs V
NYSE:HWMLong
by VROCKSTAR
BIPI Buy Position1. Trend Confirmation: Identified a Change of Character by the break of the previous high at 81, indicating a reversal in market sentiment and a new bullish trend. 2. Fair Value Gap (FVG): On the Weekly chart, identified Fair Value Gap between 69 - 71. 3. Trade Execution Entry Price: 74 ( Engulfing Candle on 5 Nov 24) SL: 66 (FVG) TP1: 110 (1.618 Fibbo) Risk-Reward Ratio (RRR): 1:4.5 Monitoring: Check-in daily closing price 4. Outcome: Exit Price: Profit/Loss: pips ------------- Disclaimer The analysis and content provided here are intended solely for personal journal and educational purposes. This information does not constitute financial advice, investment advice, or a recommendation to buy or sell any securities. Trading involves significant risk, and you should only trade with money you can afford to lose. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.
BLong
by Phoenix-Rise-Trade
LONG: Mahindra & Mahindra on the Rise: Targeting New Highs!🔍 Technical Analysis Report: NSE:M_M Current Overview: 📈 NSE:M_M have shown a strong reversal from its recent low of ₹2,665.55. This recovery is significant as it has crossed the 0.382 Fibonacci retracement level, with the highest reference point being the level 1 Fibonacci at ₹3,214.95. Key Observations: Volume Analysis: Over the past 3-5 trading days, the stock has displayed consistent positive volume, indicating sustainable upward movement. 📊🔼 Critical Resistance: Since mid-June, the stock has been approaching a key resistance level. It briefly breached the 0.5 Fibonacci level yesterday but closed near the 0.382 Fibonacci level. 🚧 Price Movement: Today, the stock opened around the 0.382 Fibonacci level at ₹2,827.10 and is inching upwards. 📈 Technical Indicators: MACD Analysis: The current MACD (Moving Average Convergence Divergence) shows an impending buying crossover. If market conditions stay favorable, we anticipate the MACD histogram turning green tomorrow, reinforcing the bullish trend. 🔄🟢 Target Levels: 🎯 First Target: ₹2,942.15 🎯 Second Target: ₹3,005.10 🚀 Extended Target (if resistance is broken): Around ₹3,100.00 Risk Management: Primary Stop-Loss: ₹2,800.00 to protect against downside risk. ⚠️ Extended Stop-Loss: ₹2,720.85 for those accommodating broader market volatility. 📉 Conclusion: 🟢 If M&M opens in the green tomorrow, this will confirm the buying trend, potentially reaching the target levels mentioned above. However, cautious trading is advised, particularly around the set stop-loss thresholds, to manage inherent market risks effectively. ⚖️ #Hashtags: #MahindraAndMahindra #StockAnalysis #TechnicalAnalysis #FibonacciLevels #MACD #TradingInsights #StockMarketIndia #BullishTrend #InvestmentStrategy #RiskManagement #FinogentSolutions Disclaimer: This analysis is for educational purposes only and should not be considered financial advice. Trading and investing involve significant risk, and you should conduct your own research or consult with a financial advisor before making any investment decisions.
NSE:M_MLong
by finogent
Southwest Airlines Co.Key arguments in support of the idea. • Changing the structure of the offer. • The shares are poised to align with their industry peers. Investment Thesis Southwest Airlines Co. (LUV) stands as a prominent leader among passenger airlines in the United States. LUV manages an extensive fleet, comprising 811 Boeing 737 aircraft. Changing the structure of the offer. Beginning in 2025, the company will start selling assigned seats priced at a minimum of 15% above the base fare. This strategic move is expected to be the primary catalyst for its share growth. By the end of 2025 or early 2026, at least 30% of cabins will be equipped with these new premium seats. Even with a marginal increase in the base fare, the airline's margin is projected to improve significantly. Despite these promising prospects, the market seems determined to overlook the future benefits that Southwest Airlines can achieve with relatively minimal effort. The shares are poised to align with their industry peers. In the past, following selloffs triggered by the carry trade effect, competitors' stocks experienced significant growth, whereas LUV demonstrated weaker performance due to ongoing proceedings with the activist fund. However, the current technical indicators appear quite favorable, and the sell-off that transpired on the day of the report release has already been recovered. We anticipate that the upward trend will persist through the end of the year. Furthermore, historical data suggests that November and December typically yield positive outcomes for this stock. For the next two months, the price target for LUV is set at $36.50, with a recommended stop-loss at $27.90.
NYSE:LUVLong
by FreedomHolding
Himadri Specialty Chem - Long Setup (Swing Trade)Himadri Specialty Chem is approaching a crucial level for a potential long trade setup. Here’s the trade plan: Entry Zone: 579.80 Entry Price: Once a 15-minute candle breaks above 579.80, the high of that candle will confirm the entry. Target: 656.3 Stop Loss: 541.55 (Stop loss will be triggered if a daily candle closes below this level) The stock is testing the entry zone at 579.80 , and if momentum builds, we could see a potential rally towards the target of 656.3 . A tight stop loss at 541.55 helps manage risk while offering a favorable risk-reward ratio for this trade. Disclaimer: This post is for educational purposes only and is not financial advice. Always manage your risk and trade responsibly
NSE:HSCLLong
by gupshupblog
Apple Report Drives Bearish Sentiment for AAPL StockApple Report Drives Bearish Sentiment for AAPL Stock Apple, the largest U.S. market-cap company, released its Q3 earnings report on October 31: → Earnings per share (EPS): Actual = $0.97, Expected = $1.60 → Gross revenue: Actual = $94.9 billion, Expected = $94.5 billion The nearly 40% miss on EPS likely disappointed investors, contributing to bearish pressure. As seen in AAPL’s chart, prices dropped below $220 — a level last seen in early September. Could the decline deepen? Today’s technical analysis of AAPL presents a few arguments for a bearish outlook: → In 2023-2024, the stock moved within a broad range between $167 and $200. When the bullish breakout of this range occurred in June 2024, $233 became a potential target, showing signs of resistance. The resistance around $233 is also reinforced by the upper boundary of a long-term ascending channel (in blue). → Trendline slopes have been gradually flattening (in purple), a sign of waning buying momentum. This weakening demand near $233 may lead to further bearish attempts to push AAPL below $220 toward the median of its long-term rising channel. Meanwhile, Wall Street analysts remain optimistic. According to TipRanks: → 23 of 34 analysts recommend buying AAPL; → The average 12-month price target is $245. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NASDAQ:AAPL
by FXOpen
2
Long from oversold conditionsLimit buy orders waiting on yellow numbers marked. I also took a small position off of the 0.5. The market is very oversold, and one look at the fundamentals tells you why that is. However there is potential for a buy out. Should this happen you would expect a short term push upwards. The technicals look really good to me and meet my conditions. The conditions are, liquidity sweep, break of structure, FVG created, entry on return to the fib areas marked. Additionally, currently the stock is correcting very nicely. Weekly momentum is overbought suggesting we could expect a deeper move down in the coming weeks, whilst monthly momentum is oversold. Lets see what happens !
NASDAQ:INTCLong
by adam_48574
Price Action - HFCLCurrent Price Action The stock has recently shown a bounce back movement from its support trendline, indicating potential strength and buyer interest. The recent high-high and high-low formations suggest strong interest in the stock, coupled with an increase in volume, which can be a bullish sign. Volume and Momentum Increased volume during the recent bounce back suggests strong participation and interest from buyers, which is a positive sign. Growth Perspective and Fundamental Analysis Product Portfolio and Diversification HFCL Ltd. has a diverse product portfolio including Optical Fiber Cable (OFC), WIFI solutions, cloud-based network management systems, and more. This diversification reduces dependence on a single product and enhances growth potential. The company serves multiple sectors such as telecom, defense, railways, utilities, and security & surveillance, both in the private and government sectors, which provides a stable and growing revenue base. Conclusion From a price action trading perspective, HFCL Ltd. shows signs of potential upside with the recent bounce back from support levels, increased volume, and bullish technical indicators. However, it is important to monitor the short-term bearish signals and adjust trading strategies accordingly.
NSE:HFCLLong
by stocktechbot
Analysis of Cipla Ltd. (NSE: CIPLA)Technical Analysis of Cipla Ltd. (NSE: CIPLA) - 30-Minute Timeframe Based on the provided chart, here are the key technical observations: Rising Wedge Pattern: Cipla is showing a rising wedge pattern on the 30-minute chart. This pattern is typically a bearish sign when it forms after an uptrend, as it indicates that buying momentum may be weakening. A breakdown from this rising wedge could signal a potential reversal, with targets at lower levels. Fibonacci Retracement Levels: Fibonacci retracement levels have been drawn on the chart, indicating potential support levels if the price begins to correct: 23.6% Level at ₹1,555.75 – Initial support if the price begins to retrace. 38.2% Level at ₹1,526.55 – A stronger support level. 50% Level at ₹1,503 – This midpoint level could serve as a significant support. The current price is hovering near ₹1,604.85, so if the rising wedge pattern breaks down, these Fibonacci levels will be key areas to monitor for support. Target Level: If Cipla breaks below the rising wedge, it could head towards the target zone near ₹1,525 (38.2% Fibonacci level) or even ₹1,500 if the selling pressure continues. Volume Analysis: The volume spike on the initial upward move shows strong buying interest, but a reduction in volume as the price approaches resistance within the wedge pattern suggests weakening bullish momentum. Fundamental Analysis of Cipla Ltd. Company Overview: Cipla is one of India's leading pharmaceutical companies, with a strong presence in the respiratory, cardiovascular, anti-retroviral, and other therapeutic segments. It is also expanding its footprint in the U.S. market. Revenue and Profit Growth: Cipla has shown consistent revenue growth driven by its domestic business and increasing exports. The company’s presence in the U.S. and other export markets adds diversification and growth opportunities. Cipla’s emphasis on high-growth therapeutic areas like respiratory and chronic diseases aligns with long-term global healthcare trends. Investment in R&D: Cipla’s focus on research and development (R&D) for specialty and generic drugs has helped the company maintain a competitive edge. This R&D investment positions Cipla well for future growth in specialty drugs, which have higher margins. Balance Sheet and Cash Flow: The company has a stable balance sheet with moderate debt levels. Cipla also has strong free cash flow generation, which supports its R&D initiatives and expansion efforts. Sector Outlook: The pharmaceutical sector has a positive outlook due to increasing healthcare needs, particularly post-pandemic, and Cipla is well-positioned to benefit from rising demand for both chronic and specialty drugs. Conclusion: Technical Outlook: Cipla is currently trading within a rising wedge pattern, which is typically bearish. A breakdown below this wedge could push the price towards support levels at ₹1,555, ₹1,526, and potentially ₹1,500. Fundamental Outlook: Cipla has strong fundamentals, driven by its diverse product portfolio, international growth, and focus on R&D. The pharmaceutical sector's positive outlook provides a supportive environment for Cipla's long-term growth.
NSE:CIPLAShort
by TheWealthyInvestorbyDSAB
NUWE - Nuwellis, Inc. Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
NASDAQ:NUWELong
by Esmail_from_Kuwait
IRCTC Breakdown Trading StrategyThe stock price of IRCTC has fallen below major support levels and currently offers good positional opportunity. The business has a monopoly and the current news flows had impacted the sentiments negatively. The news impact seems to be over and the stock is prepared to perform. Note: The idea shared is aimed at spreading practical awareness of the theoretical concept of Breakdown Trading Strategy. Do not make any financial commitments based on this.
NSE:IRCTCLong
by Gaurav_Singh_5705